PMVP

PMV Pharmaceuticals (PMVP)

PMV Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PMVP

<< 前へ 1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2021/05/08	07 : 56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/05/08	06 : 01	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/05/08	05 : 52	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/05/05	21 : 00	GlobeNewswire Inc.	PMV Pharmaceuticals Announces Participation at the Bank of America Healthcare Conference	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/05/05	08 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/04/23	21 : 33	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/04/23	21 : 31	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/04/11	02 : 31	GlobeNewswire Inc.	PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for Cancer R...	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/04/09	08 : 25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/04/09	05 : 14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/04/08	05 : 29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/04/08	05 : 25	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/04/06	21 : 51	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/04/06	21 : 00	GlobeNewswire Inc.	PMV Pharma Strengthens Board of Directors with Appointment of Dr. Charles Baum	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/04/06	08 : 05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/03/27	07 : 20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/03/26	08 : 41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/03/11	06 : 31	GlobeNewswire Inc.	PMV Pharmaceuticals Announces Presentation of PC14586 Preclinical Data at the American Association for Cancer Research (AACR)...	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/03/04	06 : 17	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/03/04	06 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/03/04	06 : 01	GlobeNewswire Inc.	PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/02/23	22 : 00	GlobeNewswire Inc.	PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/02/17	06 : 02	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/02/16	22 : 00	GlobeNewswire Inc.	PMV Pharma Appoints p53 Pioneer Dr. Guillermina Lozano to Scientific Advisory Board	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/02/16	20 : 38	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/02/13	06 : 02	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2021/02/12	20 : 12	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2020/11/25	07 : 00	GlobeNewswire Inc.	PMV Pharmaceuticals to Present at Evercore ISI 3rd Annual HealthCONx Conference	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2020/11/23	22 : 00	GlobeNewswire Inc.	PMV Pharma Doses First Patient in Phase 1/2 Study of PC14586, a First-in-Class Precision Oncology Therapy That Targets Mutant...	NASDAQ:PMVP	PMV Pharmaceuticals Inc
2020/11/13	22 : 00	GlobeNewswire Inc.	PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights	NASDAQ:PMVP	PMV Pharmaceuticals Inc